However, a recent study regarding the CSF levels of YKL-40 in prodromal AD [17] demonstrated that YKL-40 CSF levels show differences in AD versus MCI patients, implying that this inflammatory marker could predict the conversion of MCI in AD, especially in the presence of APOE ε4 allele. Here, APOE is linked to Alzheimer disease.